Influenza In Vitro

Influenza viruses (INFV) are segmented RNA viruses that cause seasonal influenza epidemics and influenza pandemics. INFV A infects birds and some mammals (e.g. pigs and humans), while VFV B only infects humans and seals. Both Influenza A and B pose a severe threat to public health and the agricultural economy. Influenza viruses mutate quickly by antigenic drift and reassortment, re- quiring the development and reformulation of new vaccines each year. Influenza strains resistant to almost all known drugs have been identified, making influenza drug development a high priority. Con- cerns about INFV have been further heightened due to the potential for transmission of highly patho- genic avian influenza (HPAI) strains to humans.

MDCK cells infected and CPE detected using a standard crystal violet staining

Vero cells infected and viral plaque detected by a standard immunoplaque assay

INFV plaque formation in PRNT assay.

IBT Bioservices continues to conduct critical work as an essential business under the State of Maryland’s COVID-19 response directive. We have implemented a risk management plan and are continually monitoring the situation to ensure continuation of research according to public health services recommended best-practices for keeping our employees and the community safe. 

The IBT Bioservices team will continue to deliver high quality products and services for every project. If you have any questions contact us at